W. Timothy Jenkins
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism 22
- Carcinogens and Genotoxicity Assessment 3
- Genetics top 5%
- Glioma Diagnosis and Treatment 7
-
- MRI in cancer diagnosis 3
- Medical Imaging Techniques and Applications 3
- Biotechnology top 5%
- Cancer Research and Treatments 5
- Bioengineering top 5%
-
- Nanoplatforms for cancer theranostics 9
-
- Mitochondrial Function and Pathology 3
- Co-authors
- Sydney M. EvansCameron J. KochStephen M. HahnC. J. KochEdith M. LordKevin W. JenkinsKevin JudyR.E. Meyn
- Partner nations
- United StatesGreeceUnited Kingdom
In The Last Decade
W. Timothy Jenkins
40 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 105
- Cancer Research 1.2k
- Genetics 326
- Radiology, Nuclear Medicine and Imaging 609
- Biotechnology 136
- Bioengineering 86
Countries citing papers authored by W. Timothy Jenkins
This map shows the geographic impact of W. Timothy Jenkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Timothy Jenkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Timothy Jenkins more than expected).
Fields of papers citing papers by W. Timothy Jenkins
This network shows the impact of papers produced by W. Timothy Jenkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Timothy Jenkins. The network helps show where W. Timothy Jenkins may publish in the future.
Co-authorship network
The 25 scholars most cited alongside W. Timothy Jenkins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 22 | |
| 2 | 2011 | 44 | |
| 3 | 2010 | 34 | |
| 4 | 2009 | 18 | |
| 5 | 2008 | 36 | |
| 6 | 2006 | 48 | |
| 7 | 2003 | 106 | |
| 8 | Radiosensitization of hypoxic tumor cells by dodecafluoropentane: a gas-phase perfluorochemical emulsion. | 2002 | 27 |
| 9 | 2002 | 6 | |
| 10 | Detection of hypoxia in human squamous cell carcinoma by EF5 binding. | 2000 | 161 |
| 11 | 2000 | 52 | |
| 12 | Noninvasive detection of tumor hypoxia using the 2-nitroimidazole [18F]EF1. | 2000 | 73 |
| 13 | 1998 | 5 | |
| 14 | 1998 | 45 | |
| 15 | 1997 | 13 | |
| 16 | 1997 | 31 | |
| 17 | 2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumors. | 1996 | 91 |
| 18 | 1996 | 62 | |
| 19 | 1982 | 2 | |
| 20 | 1979 | 7 |
About W. Timothy Jenkins
W. Timothy Jenkins is a scholar working on Cancer Research, Genetics and Biotechnology, having authored 40 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (22 papers), Nanoplatforms for cancer theranostics (9 papers), Glioma Diagnosis and Treatment (7 papers), Cancer Research and Treatments (5 papers), MRI in cancer diagnosis (3 papers), Medical Imaging Techniques and Applications (3 papers), Mitochondrial Function and Pathology (3 papers) and Carcinogens and Genotoxicity Assessment (3 papers). The work is most often cited by research in Cancer Research (1.2k citations), Genetics (326 citations) and Radiology, Nuclear Medicine and Imaging (609 citations). W. Timothy Jenkins has collaborated with scholars based in United States, Greece and United Kingdom. Frequent co-authors include Sydney M. Evans, Cameron J. Koch, Stephen M. Hahn, C. J. Koch, Edith M. Lord, Kevin W. Jenkins, Kevin Judy, R.E. Meyn, Peter T. Nelson and David F. Wilson. Their work appears in journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.